Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T15:02:39.932Z.
Calculation as of: 2026-10-06T15:02:39.932Z.
Quote observation: 2026-10-06T15:00:39.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$131.86M
EV/Sales Ratio
0.63x
TTM Avg
0.92x
3Y Avg
0.93x
5Y Avg
2.04x
Market Cap
$136.65M
EV/Sales Ratio
2.92x
TTM Avg
4.86x
3Y Avg
4.26x
5Y Avg
4.45x
Market Cap
$129.68M
EV/Sales Ratio
0.82x
TTM Avg
0.85x
3Y Avg
1.35x
5Y Avg
2.44x
Market Cap
$139.63M
EV/Sales Ratio
6.44x
TTM Avg
9.42x
3Y Avg
15.43x
5Y Avg
15.43x
Market Cap
$139.73M
EV/Sales Ratio
0.12x
TTM Avg
6.51x
3Y Avg
3.60x
5Y Avg
2.98x
Market Cap
$127.17M
EV/Sales Ratio
N/A
TTM Avg
569.53x
3Y Avg
685.92x
5Y Avg
425.88x
Market Cap
$142.15M
EV/Sales Ratio
1.29x
TTM Avg
2.03x
3Y Avg
2.11x
5Y Avg
2.84x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $133.37M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $131.86M | 0.63x | 0.92x | 0.93x | 2.04x |
| LifeMD, Inc. (LFMD)vs › | $135.17M | 0.57x | 0.71x | 1.29x | 1.09x |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.65M | 2.92x | 4.86x | 4.26x | 4.45x |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 0.82x | 0.85x | 1.35x | 2.44x |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | 6.44x | 9.42x | 15.43x | 15.43x |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 0.12x | 6.51x | 3.60x | 2.98x |
| Entera Bio Ltd. (ENTX)vs › | $127.17M | N/A | 569.53x | 685.92x | 425.88x |
| AirSculpt Technologies, Inc. (AIRS)vs › | $142.15M | 1.29x | 2.03x | 2.11x | 2.84x |
| Nyxoah S.A. (NYXH)vs › | $142.60M | 4.94x | 17.77x | 41.49x | 54.53x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
